- LFMD Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
LifeMD (LFMD) CORRESPCorrespondence with SEC
Filed: 29 Dec 20, 12:00am
Conversion Labs, Inc.
800 Third Avenue, Suite 2800
New York, New York 10022
December 29, 2020
VIA EDGAR
U.S. Securities & Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Conversion Labs, Inc. | |
Registration Statement on Form S-1 | ||
File No. 333-250985 |
Ladies and Gentlemen:
In accordance with Rule 461 of the Securities Act of 1933, as amended, Conversion Labs, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-captioned Registration Statement (the “Filing”) be accelerated so that it will be declared effective at 9:30 a.m. Eastern Time on Thursday, December 31, 2020, or as soon thereafter as possible.
* * * *
Very Truly Yours,
Conversion Labs, Inc. | |
/s/ Justin Schreiber | |
Justin Schreiber | |
Chief Executive Officer |